Literature DB >> 15023435

Male fertility preservation and cancer treatment.

Elizabeth Puscheck1, Philip A Philip, Rajasingam S Jeyendran.   

Abstract

The diagnosis of cancer in men or women leads to prompt evaluation of the extent of the cancer, its treatment, and subsequent prognosis. However, relatively little emphasis is placed on fertility following the completion of therapy. As the effectiveness of cancer treatment has improved, men can enjoy a longer life that is free of cancer. However, chemotherapeutic regimens alone or in combination with radiation therapy frequently result in azoospermia or infertility. This paper reviews available methods to maintain male fertility in patients undergoing chemotherapy or radiation therapy. Certain chemotherapeutic agents that are less likely to cause azoospermia may be incorporated into potentially curative therapies. Hormonal suppression applied early (prior to) and during chemotherapy may protect future male fertility. Alternatively, cryopreservation of sperm enables men to reproduce in the future with the assistance of in vitro fertilization with intracytoplasmic sperm injection. Therefore, oncologists need to discuss male fertility preservation before initiating cancer treatment in reproductive-aged men. The emphasis for future cancer treatment and its research regarding male fertility preservation needs further attention.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15023435     DOI: 10.1016/j.ctrv.2003.07.005

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


  8 in total

1.  Sperm banking for male reproductive preservation: a 6-year retrospective multi-centre study in China.

Authors:  Ping Ping; Wen-Bing Zhu; Xin-Zong Zhang; Kang-Shou Yao; Peng Xu; Yi-Ran Huang; Zheng Li
Journal:  Asian J Androl       Date:  2010-03-29       Impact factor: 3.285

2.  Erectile dysfunction in successfully treated lymphoma patients.

Authors:  Sercan Aksoy; Hakan Harputluoglu; Saadettin Kilickap; Murat Dincer; Omer Dizdar; Bulent Akdogan; Haluk Ozen; Mustafa Erman; Ismail Celik
Journal:  Support Care Cancer       Date:  2007-07-28       Impact factor: 3.603

3.  Cryopreservation of human sperm in patients with malignancy: First 2 years' experience.

Authors:  Hiromichi Ishikawa; Satoru Kaneko; Keisuke Miyaji; Kiyoshi Takamatsu
Journal:  Reprod Med Biol       Date:  2007-05-14

4.  Screening for y chromosome microdeletion in a nonobstructive azoospermic male patient with allogeneic bone marrow transplantation from his sister.

Authors:  Hakan Gurkan; Faruk Kucukdurmaz; Tolga Akman; Filiz Aydın; Ates Kadioglu
Journal:  Case Rep Med       Date:  2010-12-16

5.  Semen Analysis in Cancer Patients Referred for Sperm Cryopreservation before Chemotherapy over a 15-Year Period in Korea.

Authors:  Ja Yoon Ku; Nam Cheol Park; Tae Gyeong Jeon; Hyun Jun Park
Journal:  World J Mens Health       Date:  2015-04-23       Impact factor: 5.400

6.  Mkrn2 deficiency induces teratozoospermia and male infertility through p53/PERP-mediated apoptosis in testis.

Authors:  Ying-Chen Qian; Yun-Xia Xie; Chao-Shan Wang; Zhu-Mei Shi; Cheng-Fei Jiang; Yun-Yi Tang; Xu Qian; Lin Wang; Bing-Hua Jiang
Journal:  Asian J Androl       Date:  2020 Jul-Aug       Impact factor: 3.285

Review 7.  Current practices in fertility preservation in male cancer patients.

Authors:  E Charles Osterberg; Ranjith Ramasamy; Puneet Masson; Robert E Brannigan
Journal:  Urol Ann       Date:  2014-01

Review 8.  The Role of ROS as a Double-Edged Sword in (In)Fertility: The Impact of Cancer Treatment.

Authors:  Sara Mendes; Rosália Sá; Manuel Magalhães; Franklim Marques; Mário Sousa; Elisabete Silva
Journal:  Cancers (Basel)       Date:  2022-03-21       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.